Prodromal Parkinson disease signs are predicted by a whole-blood inflammatory transcriptional signature in young Pink1 -/- rats

• Published in: BMC neuroscience Vol. 25; no. 1; p. 11
• Main Authors: Lechner, Sarah A, Barnett, David G S, Gammie, Stephen C, Kelm-Nelson, Cynthia A
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.03.2024; BioMed Central; BMC
• Subjects: Adult; Age; Animals; Anxiety; Apoptosis; Biological markers; Biomarkers; Biosynthesis; Blood; Brain stem; Cell cycle; Communication; Datasets; Development and progression; Diagnosis; Fatty acids; Gene expression; Genetic aspects; Genetic transcription; Homeostasis; Humans; Inflammation; Inflammation - genetics; Interferon; Kinases; Limbs; Male; Medical examination; Movement disorders; Neurodegenerative Diseases; Neurological research; Oxidation; Parkinson disease; Parkinson Disease - genetics; Parkinson's disease; Pink1; Prion protein; Proteins; PTEN-induced putative kinase; Rat; Rats; Risk factors; RNA; RNA processing; RNA-sequencing; rRNA; Statistical analysis; Up-regulation; Vocalization behavior; Whole blood; United States; RNA-sequencing; Whole blood; Parkinson disease; Pink1; Rat
• ISSN: 1471-2202; 1471-2202
• DOI: 10.1186/s12868-024-00857-0

Parkinson disease (PD) is the fastest growing neurodegenerative disease. The molecular pathology of PD in the prodromal phase is poorly understood; as such, there are no specific prognostic or diagnostic tests. A validated Pink1 genetic knockout rat was used to model early-onset and progressive PD. Male Pink1 rats exhibit progressive declines in ultrasonic vocalizations as well as hindlimb and forelimb motor deficits by mid-to-late adulthood. Previous RNA-sequencing work identified upregulation of genes involved in disease pathways and inflammation within the brainstem and vocal fold muscle. The purpose of this study was to identify gene pathways within the whole blood of young Pink1 rats (3 months of age) and to link gene expression to early acoustical changes. To accomplish this, limb motor testing (open field and cylinder tests) and ultrasonic vocalization data were collected, immediately followed by the collection of whole blood and RNA extraction. Illumina Total RNA-Seq TruSeq platform was used to profile differential expression of genes. Statistically significant genes were identified and Weighted Gene Co-expression Network Analysis was used to construct co-expression networks and modules from the whole blood gene expression dataset as well as the open field, cylinder, and USV acoustical dataset. ENRICHR was used to identify the top up-regulated biological pathways. The data suggest that inflammation and interferon signaling upregulation in the whole blood is present during early PD. We also identified genes involved in the dysregulation of ribosomal protein and RNA processing gene expression as well as prion protein gene expression. These data identified several potential blood biomarkers and pathways that may be linked to anxiety and vocalization acoustic parameters and are key candidates for future drug-repurposing work and comparison to human datasets.